Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Type de publicationJournal Article
Year of Publication2019
AuteursWang M, Rule S, Zinzani PLuigi, Goy A, Casasnovas O, Smith S, Damaj G, Doorduijn JK, Lamy T, Morschhauser F, Panizo C, Shah B, Davies A, Eek R, Dupuis J, Jacobsen E, Kater AP, Le Gouill S, Oberic L, Robak T, Dua R, Frigault MM, Izumi R, Nguyen D, Patel P, Yin M, Jurczak W
JournalCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume19
PaginationS316
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN2152-2650
Mots-clésacalabrutinib, lymphoid malignancy, Mantle cell lymphoma, MCL, TKI
DOI10.1016/j.clml.2019.07.291